In this Q&A, Liz Beatty, co-founder and chief strategy officer at Inato, discusses how real-time patient data is reducing non-enrolling sites, why sponsor-specific technology remains the biggest ...

In a recent video interview with Applied Clinical Trials, Rob DiCicco, vice president of portfolio management at ...

In today's ACT Brief, we examine quantified reductions in trial visits through selective safety data collection, why protocol ...